# Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

> **NCT01740154** · NA · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Fatigue
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer

## Interventions

- **PROCEDURE:** transcranial magnetic stimulation
- **PROCEDURE:** electromyography
- **OTHER:** survey administration
- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT01740154
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2018-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740154, "Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01740154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*